Equities

CardioComm Solutions Inc

EKG:CVE

CardioComm Solutions Inc

Actions
Health CareMedical Equipment and Services
  • Price (CAD)0.01
  • Today's Change0.00 / 0.00%
  • Shares traded1.58m
  • 1 Year change0.00%
  • Beta-0.2950
Data delayed at least 15 minutes, as of Nov 15 2024 14:49 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CADIncome statement in CADView more

Year on year CardioComm Solutions Inc's revenues fell -11.99% from 995.81k to 876.41k. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a loss of 2.46k to a larger loss of 97.33k.
Gross margin92.09%
Net profit margin-21.94%
Operating margin-58.22%
Return on assets-35.58%
Return on equity--
Return on investment--
More ▼

Cash flow in CADView more

In 2023, CardioComm Solutions Inc increased its cash reserves by 61.53%, or 34.64k. Cash Flow from Financing totalled 90.73k or 10.35% of revenues. In addition the company used 54.07k for operations while cash used for investing totalled 2.02k.
Cash flow per share-0.0008
Price/Cash flow per share--
Book value per share-0.0035
Tangible book value per share-0.0035
More ▼

Balance sheet in CADView more

CardioComm Solutions Inc uses little or no debt in its capital structure.
Current ratio0.3399
Quick ratio0.2911
Total debt/total equity--
Total debt/total capital--
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.